Skip to main content

Table 2 Maternal and fetal demographic data and clinical characteristics of the study population. Results are presented as mean ± SD for each continuous variable unless otherwise specified

From: Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study

 

Group

Normal

PE only

FGR only

PE + FGR

Mean (Standard Deviation)

Mean (Standard Deviation)

Mean (Standard Deviation)

Mean (Standard Deviation)

Number of maternal samples

20

10

12

10

Number of cord blood / fetal samples

7

5

8

10

Maternal age (years)

28.8 ± 4.0

27.5 ± 5.8

28.3 ± 4.9

33.2 ± 6.7*#†

BMI

27.6 ± 5.4

30.3 ± 8.0

24.1 ± 5.3#

28.0 ± 6.0

Gestation age at maternal sample collection (weeks)

36.1 ± 3.8

35.2 ± 3.4

34.8 ± 4.2

31.7 ± 2.8*# †

Gestation age at delivery (weeks) all maternal samples

39.3 ± 0.8

36.5 ± 3.4*

36.2 ± 2.2*

32.0 ± 3.0*# †

Gestation age at delivery (weeks) all fetal samples

39.08 ± 0.44

36.9 ± 2.1

36 ± 2.59

32.0 ± 3.0*# †

Birth weight (g) all maternal samples

3412 ± 388

2897 ± 903*

1831 ± 781*

1398 ± 619*# †

Birth weight (g) all fetal samples

3359 ± 298

3046 ± 533

1981 ± 642

1398 ± 619*# †

Primipara (%)

40

80

58.3

90

Smoking (%)

5.6

0.0

8.3

10

Mode of delivery (LSCS) (%)

75

80

75

80

  1. *Statistically significant difference from normal pregnancy. # statistically significant difference from PE. †Statistically significant difference from FGR